| Literature DB >> 31682404 |
Aldo Isaac Martínez-Banderas1, Antonio Aires2, Marta Quintanilla2, Jorge A Holguín-Lerma3, Claudia Lozano-Pedraza4, Francisco J Teran4,5, Julián A Moreno3, Jose E Perez1, Boon S Ooi3, Timothy Ravasi1, Jasmeen S Merzaban1, Aitziber L Cortajarena2,4,5,6, Jürgen Kosel3.
Abstract
Combining different therapies into a single nanomaterial platform is a promising approach for achieving more efficient, less invasive, and personalized treatments. Here, we report on the development of such a platform by utilizing nanowires with an iron core and iron oxide shell as drug carriers and exploiting their optical and magnetic properties. The iron core has a large magnetization, which provides the foundation for low-power magnetic manipulation and magnetomechanical treatment. The iron oxide shell enables functionalization with doxorubicin through a pH-sensitive linker, providing selective intracellular drug delivery. Combined, the core-shell nanostructure features an enhanced light-matter interaction in the near-infrared region, resulting in a high photothermal conversion efficiency of >80% for effective photothermal treatment. Applied to cancer cells, the collective effect of the three modalities results in an extremely efficient treatment with nearly complete cell death (∼90%). In combination with the possibility of guidance and detection, this platform provides powerful tools for the development of advanced treatments.Entities:
Keywords: drug delivery; iron−iron oxide core−shell; magnetic cancer therapy; nanowires; photothermal therapy
Mesh:
Substances:
Year: 2019 PMID: 31682404 DOI: 10.1021/acsami.9b17512
Source DB: PubMed Journal: ACS Appl Mater Interfaces ISSN: 1944-8244 Impact factor: 9.229